Epidermal growth factor receptor (EGFR) signaling in cancer

Nicola Normanno(Yahoo (United Kingdom)), Antonella De Luca(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Caterina Bianco, Luigi Strizzi, Mario Mancino(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Monica R. Maiello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Adele Carotenuto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Gianfranco De Feo(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Francesco Caponigro(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), David Salomon(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Gene
December 28, 2005
10.1016/j.gene.2005.10.018
Cited by 2,010

Abstract

Related Papers

The EGFR family and its ligands in human cancer
Yosef Yarden|European Journal of Cancer|2001|1.6k
The tyrosine kinase inhibitor ZD1839 ("Iressa") inhibits HER2-driven signaling and suppresses the growth of HER2-overexpressing tumor cells.
Mark M. Moasser, Andrea Basso, Steven D. Averbuch et al.|PubMed|2001|508
Heregulin‐dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3.
Christian Wallasch, F. U. Weiss, Gerhard Niederfellner et al.|The EMBO Journal|1995|407
Identification of c‐erbB‐3 binding sites for phosphatidylinositol 3′‐kinase and SHC using an EGF receptor/c‐erbB‐3 chimera.
S A Prigent, William J. Gullick|The EMBO Journal|1994|356
Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone
Toshimasa Yamauchi, Kohjiro Ueki, Kazuyuki Tobe et al.|Nature|1997|284